NeuBase Therapeutics, Inc. (NBSE)
NASDAQ: NBSE · IEX Real-Time Price · USD
0.411
-0.020 (-4.56%)
Mar 28, 2024, 11:18 AM EDT - Market open
NeuBase Therapeutics Market Cap
NeuBase Therapeutics has a market cap or net worth of $1.79 million as of March 28, 2024. Its market cap has decreased by -71.39% in one year.
Market Cap
1.79M
Enterprise Value
-5.45M
1-Year Change
-71.39%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since March 28, 2019, NeuBase Therapeutics's market cap has decreased from $6.45M to $1.79M, a decrease of -72.32%. That is a compound annual growth rate of -22.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 26, 2024 | 1.32M | -52.12% |
Mar 25, 2024 | 2.76M | -2.91% |
Mar 22, 2024 | 2.84M | - |
Mar 21, 2024 | 2.84M | -3.74% |
Mar 20, 2024 | 2.95M | 3.88% |
Mar 19, 2024 | 2.84M | 1.98% |
Mar 18, 2024 | 2.79M | 4.23% |
Mar 15, 2024 | 2.67M | 6.48% |
Mar 14, 2024 | 2.51M | -1.21% |
Mar 13, 2024 | 2.54M | -3.04% |
Mar 12, 2024 | 2.62M | 1.30% |
Mar 11, 2024 | 2.59M | 0.76% |
Mar 8, 2024 | 2.57M | 3.09% |
Mar 7, 2024 | 2.49M | 0.30% |
Mar 6, 2024 | 2.48M | -1.63% |
Mar 5, 2024 | 2.52M | 4.81% |
Mar 4, 2024 | 2.41M | -2.46% |
Mar 1, 2024 | 2.47M | 4.07% |
Feb 29, 2024 | 2.37M | -1.74% |
Feb 28, 2024 | 2.41M | -5.26% |
Feb 27, 2024 | 2.55M | 0.11% |
Feb 26, 2024 | 2.54M | 29.57% |
Feb 23, 2024 | 1.96M | -5.33% |
Feb 22, 2024 | 2.07M | 4.34% |
Feb 21, 2024 | 1.99M | -2.30% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
InMed Pharmaceuticals | 2.09M |
Qualigen Therapeutics | 1.97M |
Salarius Pharmaceuticals | 1.93M |
Ampio Pharmaceuticals | 1.91M |
Allarity Therapeutics | 1.90M |
Bone Biologics | 1.85M |
NanoVibronix | 1.84M |
Virax Biolabs Group | 1.77M |